09:28 AM EDT, 03/18/2024 (MT Newswires) -- AstraZeneca ( AZN ) said Monday that eligible patients will not have to pay more than $35 per month for the pharmaceutical giant's US inhaled respiratory medicines, beginning June 1.
The medicines include Airsupra, Bevespi Aerosphere, Breztri Aerosphere, and Symbicort.
Price: 65.96, Change: -0.35, Percent Change: -0.53